Hugwil reported that a human monoclonal antibody, CLN-IgG, recognized vimentin expressing on the cell surface of the malignant tumor to reprogram cancer stem cells to normal organogenesis and thereby suppressed the progression of cancer [55]. Here, VIM is linked to cancer.